Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 136

1.

Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial.

Robertson CS, Hannay HJ, Yamal JM, Gopinath S, Goodman JC, Tilley BC; Epo Severe TBI Trial Investigators, Baldwin A, Rivera Lara L, Saucedo-Crespo H, Ahmed O, Sadasivan S, Ponce L, Cruz-Navarro J, Shahin H, Aisiku IP, Doshi P, Valadka A, Neipert L, Waguspack JM, Rubin ML, Benoit JS, Swank P.

JAMA. 2014 Jul 2;312(1):36-47. doi: 10.1001/jama.2014.6490.

PMID:
25058216
[PubMed - indexed for MEDLINE]
2.

Pragmatic Randomized Optimal Platelet and Plasma Ratios (PROPPR) Trial: Design, rationale and implementation.

Baraniuk S, Tilley BC, Del Junco DJ, Fox EE, van Belle G, Wade CE, Podbielski JM, Beeler AM, Hess JR, Bulger EM, Schreiber MA, Inaba K, Fabian TC, Kerby JD, Cohen MJ, Miller CN, Rizoli S, Scalea TM, O'Keeffe T, Brasel KJ, Cotton BA, Muskat P, Holcomb JB; PROPPR Study Group.

Injury. 2014 Sep;45(9):1287-95. doi: 10.1016/j.injury.2014.06.001. Epub 2014 Jun 10.

PMID:
24996573
[PubMed - in process]
3.

Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience.

Parashos SA, Luo S, Biglan KM, Bodis-Wollner I, He B, Liang GS, Ross GW, Tilley BC, Shulman LM; NET-PD Investigators.

JAMA Neurol. 2014 Jun;71(6):710-6. doi: 10.1001/jamaneurol.2014.391.

PMID:
24711047
[PubMed - indexed for MEDLINE]
4.

Enrollment of racially/ethnically diverse participants in traumatic brain injury trials: effect of availability of exception from informed consent.

Yamal JM, Robertson CS, Rubin ML, Benoit JS, Hannay HJ, Tilley BC.

Clin Trials. 2014 Apr;11(2):187-94. doi: 10.1177/1740774514522560.

PMID:
24686108
[PubMed - in process]
5.

Using Cognitive Pretesting in Scale Development for Parkinson's Disease: The Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Example.

Tilley BC, La Pelle NR, Goetz CG, Stebbins GT.

J Parkinsons Dis. 2014 Mar 10. [Epub ahead of print]

PMID:
24613868
[PubMed - as supplied by publisher]
6.

Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson's disease patients.

Martínez-Martín P, Rodríguez-Blázquez C, Forjaz MJ, Alvarez-Sánchez M, Arakaki T, Bergareche-Yarza A, Chade A, Garretto N, Gershanik O, Kurtis MM, Martínez-Castrillo JC, Mendoza-Rodríguez A, Moore HP, Rodríguez-Violante M, Singer C, Tilley BC, Huang J, Stebbins GT, Goetz CG.

Eur J Neurol. 2014 Mar;21(3):519-24. doi: 10.1111/ene.12349. Epub 2014 Jan 21.

PMID:
24447695
[PubMed - in process]
7.

The MDS-UPDRS Part II (motor experiences of daily living) resulted useful for assessment of disability in Parkinson's disease.

Rodriguez-Blazquez C, Rojo-Abuin JM, Alvarez-Sanchez M, Arakaki T, Bergareche-Yarza A, Chade A, Garretto N, Gershanik O, Kurtis MM, Martinez-Castrillo JC, Mendoza-Rodriguez A, Moore HP, Rodriguez-Violante M, Singer C, Tilley BC, Huang J, Stebbins GT, Goetz CG, Martinez-Martin P.

Parkinsonism Relat Disord. 2013 Oct;19(10):889-93. doi: 10.1016/j.parkreldis.2013.05.017. Epub 2013 Jun 19.

PMID:
23791519
[PubMed - indexed for MEDLINE]
8.

Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale.

Martinez-Martin P, Chaudhuri KR, Rojo-Abuin JM, Rodriguez-Blazquez C, Alvarez-Sanchez M, Arakaki T, Bergareche-Yarza A, Chade A, Garretto N, Gershanik O, Kurtis MM, Martinez-Castrillo JC, Mendoza-Rodriguez A, Moore HP, Rodriguez-Violante M, Singer C, Tilley BC, Huang J, Stebbins GT, Goetz CG.

Eur J Neurol. 2013 Apr 22. doi: 10.1111/ene.12165. [Epub ahead of print]

PMID:
23607783
[PubMed - as supplied by publisher]
9.

Unequal burden of disease, unequal participation in clinical trials: solutions from African American and Latino community members.

Ford ME, Siminoff LA, Pickelsimer E, Mainous AG, Smith DW, Diaz VA, Soderstrom LH, Jefferson MS, Tilley BC.

Health Soc Work. 2013 Feb;38(1):29-38.

PMID:
23539894
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale.

Stebbins GT, Goetz CG, Burn DJ, Jankovic J, Khoo TK, Tilley BC.

Mov Disord. 2013 May;28(5):668-70. doi: 10.1002/mds.25383. Epub 2013 Feb 13.

PMID:
23408503
[PubMed - indexed for MEDLINE]
11.

Bayesian multiple imputation for missing multivariate longitudinal data from a Parkinson's disease clinical trial.

Luo S, Lawson AB, He B, Elm JJ, Tilley BC.

Stat Methods Med Res. 2012 Dec 12. [Epub ahead of print]

PMID:
23242384
[PubMed - as supplied by publisher]
Free PMC Article
12.
13.

The health education for lupus study: a randomized controlled cognitive-behavioral intervention targeting psychosocial adjustment and quality of life in adolescent females with systemic lupus erythematosus.

Brown RT, Shaftman SR, Tilley BC, Anthony KK, Kral MC, Maxson B, Mee L, Bonner MJ, Vogler LB, Schanberg LE, Connelly MA, Wagner JL, Silver RM, Nietert PJ.

Am J Med Sci. 2012 Oct;344(4):274-82.

PMID:
22996139
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Calibration of unified Parkinson's disease rating scale scores to Movement Disorder Society-unified Parkinson's disease rating scale scores.

Goetz CG, Stebbins GT, Tilley BC.

Mov Disord. 2012 Sep 1;27(10):1239-42. doi: 10.1002/mds.25122. Epub 2012 Aug 6.

PMID:
22886777
[PubMed - indexed for MEDLINE]
15.

Expanded and independent validation of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS).

Martinez-Martin P, Rodriguez-Blazquez C, Alvarez-Sanchez M, Arakaki T, Bergareche-Yarza A, Chade A, Garretto N, Gershanik O, Kurtis MM, Martinez-Castrillo JC, Mendoza-Rodriguez A, Moore HP, Rodriguez-Violante M, Singer C, Tilley BC, Huang J, Stebbins GT, Goetz CG.

J Neurol. 2013 Jan;260(1):228-36. doi: 10.1007/s00415-012-6624-1. Epub 2012 Aug 5.

PMID:
22865238
[PubMed - indexed for MEDLINE]
16.

Fall frequency and risk assessment in early Parkinson's disease.

Voss TS, Elm JJ, Wielinski CL, Aminoff MJ, Bandyopadhyay D, Chou KL, Sudarsky LR, Tilley BC; Falls Writing Group NINDS NET-PD Investigators.

Parkinsonism Relat Disord. 2012 Aug;18(7):837-41. doi: 10.1016/j.parkreldis.2012.04.004. Epub 2012 Apr 26.

PMID:
22542094
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

A randomized recruitment intervention trial in Parkinson's disease to increase participant diversity: early stopping for lack of efficacy.

Tilley BC, Mainous AG 3rd, Elm JJ, Pickelsimer E, Soderstrom LH, Ford ME, Diaz VA, Siminoff LA, Burau K, Smith DW.

Clin Trials. 2012 Apr;9(2):188-97. doi: 10.1177/1740774512436881.

PMID:
22496398
[PubMed - indexed for MEDLINE]
18.

Contemporary outcome measures in acute stroke research: choice of primary outcome measure and statistical analysis of the primary outcome in acute stroke trials.

Tilley BC.

Stroke. 2012 Apr;43(4):935-7. doi: 10.1161/STROKEAHA.111.644864. Epub 2012 Mar 15. No abstract available.

PMID:
22426318
[PubMed - indexed for MEDLINE]
Free Article
19.

Economic analysis of secondary trial data.

Simpson KN, Tilley BC.

Prog Cardiovasc Dis. 2012 Jan-Feb;54(4):351-6. doi: 10.1016/j.pcad.2011.08.004. Review.

PMID:
22226003
[PubMed - indexed for MEDLINE]
20.

Secondary analyses in cardiovascular clinical trials - statistical and other considerations. Introduction.

Tilley BC, Davis BR.

Prog Cardiovasc Dis. 2012 Jan-Feb;54(4):329. doi: 10.1016/j.pcad.2011.11.003. No abstract available.

PMID:
22225998
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk